This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Envision Healthcare to Go Private With Acquisition by KKR
by Zacks Equity Research
Envision Healthcare to become a private company on acquisition by private equity company KKR.
Stock Market News For Jun 12, 2018
by Zacks Equity Research
U.S. stock markets continue their winning run as all three major indexes ended higher on Monday
UnitedHealth Group (UNH) Hits a 52-Week High, Can the Run Continue?
by Zacks Equity Research
UnitedHealth Group Incorporated is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for UNH for clues.
Humana (HUM) and Monida Ink Deal, Enhances In-Network Access
by Zacks Equity Research
Humana (HUM) enters into an agreement with Monida to provide better in-network access to Humana Medicare Advantage members.
Is UnitedHealth Group (UNH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is UnitedHealth Group Incorporated (UNH) Outperforming Other Medical Stocks This Year?
Why Centene (CNC) Stock More Than Doubled its Industry YTD
by Zacks Equity Research
Centene (CNC) stock surges on the back of successive Medicaid contract awards and a slew of acquisitions.
UnitedHealth Hikes Quarterly Dividend by 20%, Okays Buyback
by Zacks Equity Research
UnitedHealth (UNH) to raise its quarterly dividend by 20%. The company also refreshes its share buyback program in support of disciplined capital deployment.
Wellcare (WCG) Downgraded by Moody's on Meridian Buyout News
by Zacks Equity Research
Moody's places a downgrade rating review of WellCare Health Plans (WCG) and its unit WellCare of Florida.
Top Stock Reports for 3M, Altria & Stryker
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including 3M (MMM), Altria (MO) and Stryker (SYK).
LabCorp Extends UnitedHealthcare Pact, Lifts Diagnostics Arm
by Zacks Equity Research
LabCorp (LH) and UnitedHealthcare stretch links to collaborate on a variety of value-based programs.
Top Stock Reports for Duke Energy, Charter Communications & Abbott
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Duke Energy (DUK), Charter Communications (CHTR) and Abbott (ABT).
The Zacks Analyst Blog Highlights: UnitedHealth, United Technologies, Eni, Sanofi and Discovery
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, United Technologies, Eni, Sanofi and Discovery
3 Big Stocks with Good Growth Prospects
by James Giaquinto
3 Big Stocks with Good Growth Prospects
Is UnitedHealth Group (UNH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is UnitedHealth Group Incorporated (UNH) Outperforming Other Medical Stocks This Year?
Top Research Reports for UnitedHealth, United Technologies & Eni
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), United Technologies (UTX) and Eni (E).
Resurgent Economy, Buyouts to Keep Health Insurers Buoyant
by Zacks Equity Research
Health insurance is one of the few industries that have been able to hold up their outperformance for the past several years, irrespective of economic uncertainty and regulatory changes.
Envision Healthcare (EVHC) Q1 Earnings Beat, Revenues Rise
by Zacks Equity Research
Envision Healthcare's (EVHC) Q1 earnings gain from by revenue growth at its Physicians Services segment.
Select Medical (SEM) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Select Medical's (SEM) first-quarter results find support in bottom-line growth, higher revenues and solid segmental performances. However, rise in expenses is a downside.
LifePoint Health (LPNT) Q1 Earnings Beat, Revenues Miss
by Zacks Equity Research
LifePoint's (LPNT) Q1 earnings and revenues beat on the back of an increase in same-hospital revenues per equivalent admission.
The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum
3 Healthcare Stocks Set to Beat Q1 Earnings Estimates
by Zacks Equity Research
Elevated flu activity, aging population, high expenses, and a low tax rate would influence healthcare stocks' earnings in Q1.
Cigna Q1 Earnings Top on Higher Enrollment, 2018 View Up
by Zacks Equity Research
Cigna (CI) Q1 earnings gain from an increase in membership and revenue growth.
Humana (HUM) Tops Q1 Earnings and Revenues, Lifts Guidance
by Zacks Equity Research
Humana's (HUM) Q1 draws stength from Medicare Advantage enrollment growth, solid segmental performances, lower taxes as well as a favorable impact of share buybacks.
WellCare Health (WCG) Q1 Earnings Beat, Raises Guidance
by Zacks Equity Research
WellCare Health (WCG) Q1 earnings reflect improved performances at Medicaid Health Plans, Medicare Health Plans and Medicare PDP segments as well as favorable impact of low tax rate.
Acadia Healthcare (ACHC) Beats on Q1 Earnings and Revenues
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q1 earnings beat on revenue growth led by the addition of beds, partly offset by an increase in expenses.